Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Debio 4326 (Triptorelin)
- Development stage
- Unknown
- Lead developer
- Debiopharm
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Administration
- Intramuscular, Subcutaneous
01
Overview
Debio 4326 is a unique injectable, biodegradable, 12-month extended-release formulation of triptorelin developed for the treatment of central precocious puberty (CPP). It is designed to reduce the frequency of injections and lighten the treatment burden for children with CPP. Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist that acts by decreasing serum gonadotropin and sex hormone levels through sustained suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The formulation aims to improve long-term compliance and reduce stress for pediatric patients and their families. Debio 4326 is currently in Phase 3 clinical trials[1][2][3][5][7].
- Other names
- Debio 4326Debio4326Debio-4326triptorelin acetate
02
Targets
GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on Debio 4326 (Triptorelin).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Debio 4326 (Triptorelin).